Santhera Pharmaceuticals Holding AG SPHDF
SPHDF
Santhera Pharmaceuticals Holding AG GNFTF
Genfit S.A. JWCTF
JW (Cayman) Therapeutics Co. Ltd SLNCF
Silence Therapeutics plc MLLCF
Molecular Partners AG BRIBF
Brii Biosciences Limited BXPHF
Botanix Pharmaceuticals Limited IPHYF
Innate Pharma S.A. NDTP
NDT Pharmaceuticals Inc. ORYZF
Oryzon Genomics S.A.
Santhera Pharmaceuticals Holding AG GNFTF
Genfit S.A. JWCTF
JW (Cayman) Therapeutics Co. Ltd SLNCF
Silence Therapeutics plc MLLCF
Molecular Partners AG BRIBF
Brii Biosciences Limited BXPHF
Botanix Pharmaceuticals Limited IPHYF
Innate Pharma S.A. NDTP
NDT Pharmaceuticals Inc. ORYZF
Oryzon Genomics S.A.
Performance
| Periode | SPHDF | GNFTF | JWCTF | SLNCF | MLLCF | BRIBF | BXPHF | IPHYF | NDTP | ORYZF |
|---|---|---|---|---|---|---|---|---|---|---|
| 6M | -9.49 % | 16.95 % | 44.00 % | 36.36 % | -17.06 % | -7.46 % | -72.81 % | 10.51 % | 1 266.91 % | 4.35 % |
| YTD | 41.72 % | 16.95 % | 122.22 % | -14.45 % | -14.84 % | 91.79 % | -75.36 % | -25.69 % | 3 484.91 % | 107.41 % |
| 1Y | 41.72 % | 20.35 % | 123.05 % | 0.00 % | -14.84 % | 91.79 % | -75.36 % | -25.69 % | 3 484.91 % | 107.41 % |
| 3Y | -99.05 % | 24.32 % | -29.36 % | -30.77 % | -41.28 % | -74.67 % | 215.40 % | -31.15 % | 1 800.00 % | 37.14 % |
| 5Y | 41 076 823.08 % | -12.84 % | -87.37 % | -61.86 % | -85.42 % | -91.25 % | -28.32 % | -49.88 % | -47.22 % | -25.33 % |
| 10Y | 1 530 963 302 652.29 % | -88.00 % | -87.37 % | -22.41 % | -84.53 % | -91.25 % | -60.58 % | -84.85 % | 1 800.00 % | -6.67 % |
| From the beginning | 29 666 666 566.67 % | -85.60 % | -87.37 % | -10.00 % | -84.53 % | -91.25 % | -60.58 % | -86.12 % | -99.63 % | -6.67 % |